Emerald Advisors’s Eli Lilly LLY Stock Holding History

Emerald Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Buy	1,318 +158	+14%	+$161K	0.2%	38
2026 Q1	$1.07M	Buy	1,160 +69	+6%	+$70K	0.13%	48
2025 Q4	$1.17M	Buy	1,091 +6	+0.6%	+$5.74K	0.16%	47
2025 Q3	$828K	Buy	1,085 +64	+6%	+$47.6K	0.11%	55
2025 Q2	$796K	Buy	1,021 +386	+61%	+$300K	0.1%	55
2025 Q1	$524K	Hold	635	–	–	0.07%	63
2024 Q4	$490K	Hold	635	–	–	0.07%	62
2024 Q3	$583K	Hold	635	–	–	0.08%	58
2024 Q2	$575K	Hold	635	–	–	0.09%	56
2024 Q1	$494K	Hold	635	–	–	0.09%	59
2023 Q4	$370K	Hold	635	–	–	0.07%	65
2023 Q3	$341K	Buy	635 +1	+0.2%	+$515	0.08%	64
2023 Q2	$297K	Buy	634 +1	+0.2%	+$419	0.07%	69
2023 Q1	$217K	Sell	633 -6	-0.9%	-$2.02K	0.06%	76
2022 Q4	$234K	Buy	639 +17	+3%	+$6.03K	0.06%	66
2022 Q3	$201K	Buy	622 +1	+0.2%	+$317	0.06%	74
2022 Q2	$201K	Buy	+621	New	+$186K	0.06%	81

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Emerald Advisors's LLY Position: Q2 2026 in Review

Emerald Advisors increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $161K and bringing the position to 1,318 shares worth $1.58M. The position accounts for 0.2% of the portfolio, ranked #38.

Emerald Advisors first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 876 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Emerald Advisors held 1,318 shares of Eli Lilly worth $1.58M as of Q2 2026.
Emerald Advisors bought 158 Eli Lilly shares in Q2 2026, an estimated $161K.
Eli Lilly made up 0.2% of Emerald Advisors's portfolio in Q2 2026, its #38 holding.
Emerald Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
876 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Emerald Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.